Loading
Life sciences · Journal article
Discover Bacteria. · August 25, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a retrospective descriptive trend analysis using Global Burden of Disease 2021 modelled estimates to characterise mortality attributed to antimicrobial-resistant A. baumannii in Pakistan from 1990 to 2021 across seven antibiotic classes. Overall age-standardised mortality declined 41% over the period, but carbapenem resistance remained the largest individual drug-class burden. The findings are observational only and provide no evidence of causation, intervention efficacy, or mechanism; they serve primarily as an epidemiological baseline for national planning.
Retrospective trend analysis using global burden of disease modelling. Pakistan population, all ages, both sexes combined. Deaths attributed to antimicrobial resistance in Acinetobacter baumannii across seven antibiotic classes.. Intervention: None; observational trend analysis. Compared with: None; single-country time-series comparison. Pakistan.
Overall age-standardised death rate attributable to AMR in A. baumannii decreased by 41.0% from 5.767 (95% UI 4.885–6.649) per 100,000 in 1990 to 3.403 (2.876–3.931) per 100,000 in 2021, after peaking at 6.544 in 1999. Carbapenems carried the highest individual-class burden throughout the study period, declining 30.6% from 2.277 per 100,000 in 1990 to 1.581 (1.203–1.959) in 2021. Anti-pseudomonal penicillin/beta-lactamase inhibitor combinations showed the largest relative decline at −79.8%, followed by fourth-generation cephalosporins (−79.1%) and third-generation cephalosporins (−73.1%).
No intervention, comparator group, or causal analysis; trends are descriptive only and may reflect changes in surveillance, coding, or population health rather than true mortality burden.
Clinicians and public health authorities in Pakistan should note that while mortality attributed to AMR in A. baumannii has declined overall, carbapenem-resistant strains remain the largest single drug-class burden. These modelled trends provide epidemiological context for national antimicrobial stewardship policy but do not establish causation or validate any specific intervention; additional primary data collection and clinical trials are needed to identify effective control strategies.
Descriptive epidemiological analysis of GBD modelled estimates over time in one country; documents trends but lacks causal design, intervention, or comparator and relies on computational imputation rather than primary data collection.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and public health authorities in Pakistan should note that while mortality attributed to AMR in A. baumannii has declined overall, carbapenem-resistant strains remain the largest single drug-class burden. These modelled trends provide epidemiological context for national antimicrobial stewardship policy but do not establish causation or validate any specific intervention; additional primary data collection and clinical trials are needed to identify effective control strategies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Acinetobacter baumannii is classified as a critical-priority pathogen by the World Health Organization due to its high capacity for antimicrobial resistance (AMR). Despite being a leading cause of healthcare-associated infections globally, Pakistan-specific temporal trends in mortality attributable to drug-resistant A. baumannii across multiple antibiotic classes remain poorly characterised. This study quantifies trends in the age-standardised mortality rate attributable to AMR in A. baumannii for seven antibiotic classes in Pakistan from 1990 to 2021. Data were extracted from the Global Burden of Disease (GBD) 2021 study using the IHME Measuring Infectious Causes and Resistance Outcomes for Burden Estimation (MICROBE) tool. Age-standardised death rates per 100,000 population attributable to AMR in A. baumannii were obtained for Pakistan (both sexes combined) across seven antibiotic classes and a composite measure of resistance to one or more antibiotics, from 1990 to 2021. Point estimates with 95% uncertainty intervals are reported (UIs) derived from 100 posterior draws of the GBD estimation process. Absolute and relative changes between 1990 and 2021 were calculated for each drug class. The overall age-standardised death rate attributable to resistance to one or more antibiotics in A. baumannii decreased by 41·0% from 5·767 (95% UI 4·885–6·649) per 100,000 in 1990 to 3·403 (2·876–3·931) in 2021, after peaking at 6·544 in 1999. Carbapenems carried the highest individual-class burden throughout the study period, with a death rate of 2·277 in 1990, peaking at 2·980 in 2004, and declining to 1·581 (1·203–1·959) in 2021 (− 30·6%). The largest relative declines were observed for anti-pseudomonal penicillin/beta-lactamase inhibitor combinations (− 79·8%), fourth-generation cephalosporins (− 79·1%), and third-generation cephalosporins (− 73·1%). Beta-lactam/beta-lactamase inhibitor resistance was the only class showing a marginal increase (+ 5·9%). Fluoroquinolone resistance showed an inverted-U pattern, peaking at 1·599 in 2010 before declining to 0·938 (0·739–1·137) in 2021. Despite overall reductions, AMR-attributable mortality from A. baumannii in Pakistan remains substantial, with carbapenems accounting for the largest drug-class-specific burden. The persistent dominance of carbapenem resistance underscores the urgent need for strengthened antimicrobial stewardship, infection prevention in healthcare facilities, and investment in novel therapeutic agents. These findings provide a critical evidence base for national AMR action planning in Pakistan.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.